Related Experiment Video
Updated: Aug 7, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Genetic background controls tumor development in PTEN-deficient mice
Dan Freeman1, Ralf Lesche, Nathalie Kertesz
1Department of Molecular and Medical Pharmacology, University of California at Los Angeles School of Medicine, 650 C.E. Young Drive South, Los Angeles, CA 90095, USA.
Genetic background significantly impacts cancer development in Pten mutation mouse models. Tumor formation and progression depend more on the genetic environment than the specific Pten gene mutation.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- PTEN is a crucial tumor suppressor gene frequently mutated in human cancers.
- Germline PTEN mutations cause rare autosomal-dominant disorders with variable phenotypes.
- Identical PTEN mutations can manifest as different clinical disorders, suggesting modifier effects.
Purpose of the Study:
- To investigate the influence of genetic background on PTEN-controlled tumorigenesis.
- To determine if modifier genes affect the phenotype of PTEN mutations.
- To establish genotype-phenotype correlations in PTEN-related disorders using mouse models.
Main Methods:
- Generated genetically engineered mouse models with specific Pten gene deletions (exon 5 or promoter to exon 3).
- Compared tumor formation phenotypes of these models on two different genetic backgrounds.
- Analyzed the onset, spectrum, and progression of tumors in relation to mutation type and genetic background.
Main Results:
- Tumorigenesis onset and spectrum were significantly influenced by the genetic background.
- The type of Pten mutation had a lesser impact on tumor formation compared to genetic background.
- Genetic background plays a critical role in modulating PTEN-driven tumorigenesis.
Conclusions:
- PTEN is essential for cancer development, but its effects are significantly modified by the host's genetic makeup.
- Genetic background is a key determinant of tumorigenesis in PTEN mutation carriers.
- Understanding genetic modifiers is crucial for predicting and potentially treating PTEN-related cancer syndromes.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
08:57Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Related Concept Videos
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
In-vitro Mutagenesis